Astrocyte Pharmaceuticals Inc.
Drug to treat stroke, TBI, concussion; efficacy and safety proven in rats, pigs, monkeys; Ser A for human Ph 1 led by Boston Harbor Angels (78% full)
Astrocyte Pharmaceuticals is a pre-IND neuroscience drug development company with a novel small molecule drug for the treatment of stroke, traumatic brain injury and concussion. The company has demonstrated significant neuroprotective efficacy in mouse, rat, pig, and non-human primate models, with acute treatment administered as late as 24 hours post injury. The company has raised ~$9M in public and private investment.